# Bausch & Lomb Corp: filings

BLCO · NYSE · CIK 1860742 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/blco.md) · [Financials](/companies/blco/financials.md) · [Filings](/companies/blco/filings.md) · [Insiders](/companies/blco/insiders.md)

## Reports and events: 84 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 207, 8-K 53, 3 26, 10-Q 15, UPLOAD 6, 144 5, 8-K/A 5, CORRESP 5, 10-K 4, ARS 4, DEF 14A 4, DRSLTR 4, DRS/A 3, S-8 3, 3/A 2, 4/A 2, DEFA14A 2, S-1/A 2, SD 2, 144/A 1, 424B4 1, 8-A12B 1, CERT 1, DRS 1, EFFECT 1, S-1 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 16:39 ET | [8-K](/filings/0001193125-26-436254.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-436254 |
| 2026-10-28 | 16:25 ET | [10-Q](/filings/0001860742-26-000111.md) | Quarterly report, period 2026-09-30 | 0001860742-26-000111 |
| 2026-10-28 | 07:03 ET | [8-K](/filings/0001860742-26-000108.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001860742-26-000108 |
| 2026-10-13 | 06:09 ET | [8-K](/filings/0000950103-26-015460.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950103-26-015460 |
| 2026-08-12 | 07:01 ET | [8-K/A](/filings/0000950103-26-012223.md) | 5.02 Departure or appointment of officers or directors | 0000950103-26-012223 |
| 2026-08-06 | 07:10 ET | [8-K](/filings/0000950103-26-011979.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-26-011979 |
| 2026-07-29 | 16:17 ET | [10-Q](/filings/0001860742-26-000088.md) | Quarterly report, period 2026-06-30 | 0001860742-26-000088 |
| 2026-07-29 | 07:02 ET | [8-K](/filings/0001860742-26-000086.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001860742-26-000086 |
| 2026-05-20 | 16:32 ET | [8-K](/filings/0001193125-26-232712.md) | 5.07 Shareholder vote results | 0001193125-26-232712 |
| 2026-04-29 | 16:36 ET | [10-Q](/filings/0001860742-26-000062.md) | Quarterly report, period 2026-03-31 | 0001860742-26-000062 |
| 2026-04-29 | 07:01 ET | [8-K](/filings/0001860742-26-000060.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001860742-26-000060 |
| 2026-04-10 | 16:05 ET | [DEF 14A](/filings/0001140361-26-014234.md) | Proxy statement, period 2026-05-20 | 0001140361-26-014234 |
| 2026-02-18 | 17:19 ET | [10-K](/filings/0001860742-26-000007.md) | Annual report, period 2025-12-31 | 0001860742-26-000007 |
| 2026-02-18 | 07:01 ET | [8-K](/filings/0001860742-26-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001860742-26-000006 |
| 2026-01-02 | 16:10 ET | [8-K](/filings/0000950103-26-000051.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-26-000051 |
| 2025-12-22 | 16:10 ET | [8-K/A](/filings/0001860742-25-000035.md) | 5.02 Departure or appointment of officers or directors | 0001860742-25-000035 |
| 2025-12-17 | 16:44 ET | [8-K](/filings/0001193125-25-322866.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-322866 |
| 2025-12-12 | 17:29 ET | [8-K](/filings/0000950103-25-016088.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-25-016088 |
| 2025-11-13 | 07:24 ET | [8-K](/filings/0000950103-25-014656.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950103-25-014656 |
| 2025-10-29 | 16:31 ET | [10-Q](/filings/0001860742-25-000023.md) | Quarterly report, period 2025-09-30 | 0001860742-25-000023 |
| 2025-10-29 | 07:02 ET | [8-K](/filings/0001860742-25-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001860742-25-000021 |
| 2025-08-18 | 17:06 ET | [8-K](/filings/0001860742-25-000019.md) | 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001860742-25-000019 |
| 2025-07-30 | 17:17 ET | [10-Q](/filings/0001860742-25-000018.md) | Quarterly report, period 2025-06-30 | 0001860742-25-000018 |
| 2025-07-30 | 07:00 ET | [8-K](/filings/0001860742-25-000016.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001860742-25-000016 |
| 2025-07-23 | 16:56 ET | [8-K](/filings/0000950103-25-009183.md) | 5.02 Departure or appointment of officers or directors | 0000950103-25-009183 |
| 2025-06-27 | 07:33 ET | [8-K](/filings/0001193125-25-149726.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-149726 |
| 2025-06-18 | 16:52 ET | [8-K](/filings/0000950103-25-007603.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-25-007603 |
| 2025-06-10 | 09:05 ET | [8-K](/filings/0000950103-25-007189.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-25-007189 |
| 2025-05-21 | 16:36 ET | [8-K](/filings/0001193125-25-124034.md) | 5.07 Shareholder vote results | 0001193125-25-124034 |
| 2025-05-21 | 19:39 ET | [8-K](/filings/0000950103-25-006266.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-25-006266 |
| 2025-04-30 | 16:17 ET | [10-Q](/filings/0001860742-25-000008.md) | Quarterly report, period 2025-03-31 | 0001860742-25-000008 |
| 2025-04-30 | 07:02 ET | [8-K](/filings/0001860742-25-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001860742-25-000007 |
| 2025-04-10 | 16:02 ET | [DEF 14A](/filings/0001140361-25-013244.md) | Proxy statement, period 2025-05-21 | 0001140361-25-013244 |
| 2025-02-19 | 16:47 ET | [10-K](/filings/0001860742-25-000004.md) | Annual report, period 2024-12-31 | 0001860742-25-000004 |
| 2025-02-19 | 07:01 ET | [8-K](/filings/0001860742-25-000003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001860742-25-000003 |
| 2024-11-01 | 16:27 ET | [8-K](/filings/0000950103-24-015809.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950103-24-015809 |
| 2024-10-30 | 16:32 ET | [10-Q](/filings/0001860742-24-000018.md) | Quarterly report, period 2024-09-30 | 0001860742-24-000018 |
| 2024-10-30 | 07:04 ET | [8-K](/filings/0001860742-24-000016.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001860742-24-000016 |
| 2024-08-01 | 16:17 ET | [10-Q](/filings/0001860742-24-000014.md) | Quarterly report, period 2024-06-30 | 0001860742-24-000014 |
| 2024-07-31 | 07:06 ET | [8-K](/filings/0001860742-24-000011.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001860742-24-000011 |
| 2024-05-29 | 16:44 ET | [8-K](/filings/0001193125-24-149259.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-24-149259 |
| 2024-05-01 | 16:47 ET | [10-Q](/filings/0001860742-24-000008.md) | Quarterly report, period 2024-03-31 | 0001860742-24-000008 |
| 2024-05-01 | 07:02 ET | [8-K](/filings/0001860742-24-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001860742-24-000007 |
| 2024-04-29 | 16:06 ET | [DEF 14A](/filings/0001308179-24-000628.md) | Proxy statement, period 2024-05-29 | 0001308179-24-000628 |
| 2024-02-28 | 08:12 ET | [8-K](/filings/0001193125-24-049266.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-049266 |
| 2024-02-21 | 16:55 ET | [10-K](/filings/0001860742-24-000004.md) | Annual report, period 2023-12-31 | 0001860742-24-000004 |
| 2024-02-21 | 07:00 ET | [8-K](/filings/0001860742-24-000003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001860742-24-000003 |
| 2023-11-13 | 16:47 ET | [8-K/A](/filings/0001193125-23-276133.md) | 9.01 Financial statements and exhibits | 0001193125-23-276133 |
| 2023-11-07 | 17:00 ET | [8-K/A](/filings/0001860742-23-000032.md) | 5.02 Departure or appointment of officers or directors | 0001860742-23-000032 |
| 2023-11-01 | 17:03 ET | [10-Q](/filings/0001860742-23-000029.md) | Quarterly report, period 2023-09-30 | 0001860742-23-000029 |

Page 1 of 2. [Older](/companies/blco/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 18:28 ET. No prices; not investment advice.